BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9574558)

  • 1. Down-regulation of CXCR2 expression on human polymorphonuclear leukocytes by TNF-alpha.
    Asagoe K; Yamamoto K; Takahashi A; Suzuki K; Maeda A; Nohgawa M; Harakawa N; Takano K; Mukaida N; Matsushima K; Okuma M; Sasada M
    J Immunol; 1998 May; 160(9):4518-25. PubMed ID: 9574558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis.
    Cummings CJ; Martin TR; Frevert CW; Quan JM; Wong VA; Mongovin SM; Hagen TR; Steinberg KP; Goodman RB
    J Immunol; 1999 Feb; 162(4):2341-6. PubMed ID: 9973513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-alpha-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression.
    Khandaker MH; Mitchell G; Xu L; Andrews JD; Singh R; Leung H; Madrenas J; Ferguson SS; Feldman RD; Kelvin DJ
    Blood; 1999 Apr; 93(7):2173-85. PubMed ID: 10090924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T lymphocytes and mast cells differentially express and regulate extra- and intracellular CXCR1 and CXCR2.
    Lippert U; Zachmann K; Henz BM; Neumann C
    Exp Dermatol; 2004 Aug; 13(8):520-5. PubMed ID: 15265017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism.
    Khandaker MH; Xu L; Rahimpour R; Mitchell G; DeVries ME; Pickering JG; Singhal SK; Feldman RD; Kelvin DJ
    J Immunol; 1998 Aug; 161(4):1930-8. PubMed ID: 9712063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Ca2+-dependent autoregulation of lipopolysaccharide-induced IL-8 receptor expression in human polymorphonuclear neutrophils.
    Bhattacharya C; Samanta S; Gupta S; Samanta AK
    J Immunol; 1997 Feb; 158(3):1293-301. PubMed ID: 9013972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor alpha regulates CXC chemokine receptor expression and function.
    Jawa RS; Quaid GA; Williams MA; Cave CM; Robinson CT; Babcock GF; Lieberman MA; Witt D; Solomkin JS
    Shock; 1999 Jun; 11(6):385-90. PubMed ID: 10454826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells.
    Lippert U; Artuc M; Grützkau A; Möller A; Kenderessy-Szabo A; Schadendorf D; Norgauer J; Hartmann K; Schweitzer-Stenner R; Zuberbier T; Henz BM; Krüger-Krasagakes S
    J Immunol; 1998 Sep; 161(5):2600-8. PubMed ID: 9725262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2.
    Feniger-Barish R; Ran M; Zaslaver A; Ben-Baruch A
    Cytokine; 1999 Dec; 11(12):996-1009. PubMed ID: 10623425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
    Wuyts A; Proost P; Lenaerts JP; Ben-Baruch A; Van Damme J; Wang JM
    Eur J Biochem; 1998 Jul; 255(1):67-73. PubMed ID: 9692902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties.
    Wuyts A; Van Osselaer N; Haelens A; Samson I; Herdewijn P; Ben-Baruch A; Oppenheim JJ; Proost P; Van Damme J
    Biochemistry; 1997 Mar; 36(9):2716-23. PubMed ID: 9054580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of polymorphonuclear leukocyte cytokine receptor expression: the role of altered oxygen tensions and matrix proteins.
    Simms H; D'Amico R
    J Immunol; 1996 Oct; 157(8):3605-16. PubMed ID: 8871661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils regulate their own apoptosis via preservation of CXC receptors.
    Dunican A; Grutkoski P; Leuenroth S; Ayala A; Simms HH
    J Surg Res; 2000 May; 90(1):32-8. PubMed ID: 10781372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD45 modulation of CXCR1 and CXCR2 in human polymorphonuclear leukocytes.
    Mitchell GB; Khandaker MH; Rahimpour R; Xu L; Lazarovits AI; Pickering JG; Suria H; Madrenas J; Pomerantz DK; Feldman RD; Kelvin DJ
    Eur J Immunol; 1999 May; 29(5):1467-76. PubMed ID: 10359100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
    Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
    Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils.
    Bonecchi R; Polentarutti N; Luini W; Borsatti A; Bernasconi S; Locati M; Power C; Proudfoot A; Wells TN; Mackay C; Mantovani A; Sozzani S
    J Immunol; 1999 Jan; 162(1):474-9. PubMed ID: 9886422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of IL-1, IL-2, and tumor necrosis factor on polymorphonuclear leukocyte Fc gamma receptor-mediated phagocytosis. IL-2 down-regulates the effect of tumor necrosis factor.
    Moxey-Mims MM; Simms HH; Frank MM; Lin EY; Gaither TA
    J Immunol; 1991 Sep; 147(6):1823-30. PubMed ID: 1890305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal in vitro CXCR2 modulation and defective cationic ion transporter expression on polymorphonuclear neutrophils responsible for hyporesponsiveness to IL-8 stimulation in patients with active systemic lupus erythematosus.
    Hsieh SC; Wu TH; Tsai CY; Li KJ; Lu MC; Wu CH; Yu CL
    Rheumatology (Oxford); 2008 Feb; 47(2):150-7. PubMed ID: 18208820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
    Niiya M; Niiya K; Kiguchi T; Shibakura M; Asaumi N; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Ueoka H; Tanimoto M
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interruption of G protein-coupling in CXCR2 does not alter ligand binding, but eliminates ligand-activation of GTPgamma35S binding, calcium mobilization, and chemotaxis.
    Yang W; Schraw WP; Mueller SG; Richmond A
    Biochemistry; 1997 Dec; 36(49):15193-200. PubMed ID: 9398246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.